Obesity diabetes and dyslipidemia as determinants of immune checkpoint inhibitors response in non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This ...
In order to expel these functional variants from the cell, Professor Garbers and his team want to outsmart the ‘chaperones’ of ER quality control. In a first step, the researchers therefore want to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results